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Multiple self-healing squamous epithelioma (MSSE), also known as Ferguson–Smith Disease, is a rare cancer-
associated genodermatosis with an autosomal dominant inheritance. Affected patients suffer from recurrent
skin lesions, which clinically and histologically resemble keratoacanthomas or well-differentiated squamous
cell carcinomas, but which, if left, undergo spontaneous regression, leaving pronounced scarring. The majority
of MSSE cases previously described were of Scottish ancestry and all shared the same at-risk haplotype,
suggesting that this disorder was caused by a founder mutation. The candidate locus for MSSE lies in a region of
o4 cM in chromosome 9q22, between the markers D9S197 and D9S1809. We recently investigated MSSE families
of non-Scottish origin. For every patient of these families, we obtained a detailed clinical history, with particular
attention to the age of onset, distribution, and clinical course of their skin lesions. Once confirmed that they
were really affected by MSSE, we performed haplotype analysis on them and their families. The haplotypes for
polymorphic markers segregating with MSSE in non-Scottish and Scottish families differ, suggesting that MSSE
is not caused by a founder mutation and might be more common than originally thought.
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INTRODUCTION
Multiple self-healing squamous epithelioma (MSSE), also
known as Ferguson–Smith Disease, is a familial genoderma-
tosis characterized by the occurrence of multiple skin tumors,
which histologically cannot be distinguished from well-
differentiated squamous cell carcinomas (SCCs), but which
undergo spontaneous regression like keratoacanthomas
(KAs), resulting in characteristic scar formation. One of the
features distinguishing this condition from eruptive KA of the
Grzybowski variant is its familial nature (Consigli et al.,
2000). MSSE was first described in a 23-year-old Scottish
coalminer (Ferguson-Smith, 1934). It is a rare genodermatosis
inherited as an autosomal dominant trait. Less than 200 cases
have been described so far, the majority originating from
West and Central Scotland, traced to two common ancestors
around the beginning of the 19th century (Ferguson-Smith
et al., 1971).
The age of onset of MSSE is variable with the appearance
of first tumors ranging from 8 to 62 years (Goudie et al.,
1993). Further tumors appear episodically throughout life.
Lesions are typically painless and multiple, with over 100
tumors developing in some affected individuals over their
lifetime. Tumors arise predominantly, but not exclusively, on
sun-exposed areas of the face, scalp, ears, forearms, and legs.
They first appear as red papules and progress to nodules,
often with a central keratin plug. Over time the lesions may
ulcerate; when ulceration occurs, the edges are typically
rolled and undermined. Characteristically, these tumors
undergo spontaneous regression within 4–6 months, resulting
in scars that are typically deep and pitted on the face, scalp,
and ears, although those on the limbs tends to be smoother
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and shallower. Considerable morbidity is associated with
disfiguring scarring. The tumors invade locally and may be
destructive but do not appear to recur following excision.
Aggressive local invasion after radiotherapy is very rare,
although it has been reported in a patient who underwent
radiotherapy (Chakrabarty and Perks, 1996). Treatment with
etretinate was found to prevent new lesions from developing
in some patients (Wright et al., 1988), but the most successful
treatments are surgical excision of the lesions or cryotherapy.
Eleven MSSE families with 49 affected and 104 unaffected
individuals originating from West and Central Scotland have
previously been subjected to linkage analysis. The candidate
locus for MSSE was refined to a region of o4 cM in
chromosome 9q22 between the markers D9S197 and
D9S1809 (Goudie et al., 1993; Richards et al., 1997).
Affected members of nine of the 11 families shared a
common haplotype for all the markers in the candidate
region, suggesting common ancestry. Although MSSE has
been known as a well-defined disorder for more than 60
years, no detailed paper describing the clinical features has
been published since 1971 (Ferguson-Smith et al., 1971). Our
report includes a description of the common clinical features
of the patients studied, the results of linkage analysis in more
recently acquired Scottish MSSE families and MSSE patients
of non-Scottish origin, and results of the mutations screening
in some candidate genes that lie in the MSSE region, between
markers D9S197 and D9S1809.
RESULTS
Histological analysis of the tumors from the MSSE patients
Histological analysis was conducted on several tumors from
each MSSE patient reported in this paper. In all cases, the
lesions were confirmed to be KAs or well-differentiated SCCs.
Figure 1 shows a low power micrograph of a skin lesion
removed from the forearm of a 44-year-old MSSE female
patient from the Scottish kindred. The lesion lacks the
collarette of epidermis on either edge, and the distinctive
eosinophilic cytoplasm observed in a KA. When viewed at
higher power, there is no obvious epithelial atypia, there are
few mitoses in the epithelium and the inflammatory infiltrate
is mixed. A single microabcess is seen. This lesion has the
features of a well-differentiated SCC.
Clinical assessment of the patients
The clinical features of 37 patients of Scottish origin and of 19
affected persons of non-Scottish origin were examined and
found to be similar, in almost every aspect, to the cases
described by Ferguson-Smith (1934) and Ferguson-Smith
et al. (1971).
Of the 37 Scottish patients, 11 were males (29.73%) and
26 were females (70.27%). The mean age of onset was 25.1
years (Figure 2): 26.3 years in male subjects (range, 12–50)
and 24.6 years in female subjects (range, 8–63). A total of 97
tumors were observed in the 11 male patients and the
average number of tumors was 8.82 (range, 3–15). A total of
637 tumors were observed in the 26 female patients, and the
average number of tumors per patient was 24.5 (range,
1–133). All patients had at least one tumor on the head. In
both male and female patients, the majority of tumors (82%
and 72%, respectively) were located on the head with fewer
tumors on the trunk and limbs. The tumor distribution,
according to anatomical location, is illustrated in Table 1.
Two cases, MA1.2 and MA2.1, are here described in more
detail. MA1.2 is a 78-year-old female born in west Scotland,
who emigrated to Australia aged 51. She developed her first
lesion, aged 50, on her right lateral malleolus, which cleared
spontaneously after 1 year, leaving a 1 cm scar. A second
tumor was excised on the dorsum of her left hand a few
months later. Subsequently, more than 25 tumors developed
on her face, nose, and ears. These were either surgically
removed or left untreated to heal spontaneously (within an
average of 6 months). Her father died of intra-oral SCC.
MA2.1, the son of MA1.2, who is in his fifties, developed
his first lesion on his left eyebrow aged 15. This sponta-
neously resolved, but, in the following year, several other
lesions appeared on his lower face and in the lobes of both
his ears. All resolved spontaneously, within 7 weeks on
average. When MA2.1 was in his early 20s, he developed
several lesions on both his cheeks and ears, on his left
eyebrow and on his jaw line; all these lesions were surgically
removed. Similar lesions came and went in the same areas in
the following years, and six of them were surgically removed.
A bigger benign tumor developed on his tongue on his late
20s, it was left untreated and still has not resolved. In total,
Figure 1. Histological section from a typical MSSE lesion. The symmetry and
architecture of this lesion can resemble a KA, but the collarette of epidermis
on the edge and the eosinophilic cytoplasm, typical of a KA, are absent. When
examined at higher power magnification, epithelial atypia is not prominent,
fewer than normal mitoses are present, and the inflammatory infiltrate is
mixed. A single microabcess is seen. (hematoxylin and eosin; Bar: 100 mm)
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Figure 2. Age of MSSE onset in the Scottish patients. Fifty percent of the
Scottish patients were affected by the age of 26 years. By the age of 65, 97%
of the patients were affected. Censored patients are shown by the vertical line.
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MA2.1 has developed more than 50 lesions on his face,
ears, and neck, as his first one was diagnosed, with
new ones appearing every few months. The most uncomfor-
table tumors were excised, whereas the others were left
to heal spontaneously. Histology is not yet available on
this subject.
The non-Scottish patients assessed included three mem-
bers from an Italian family (Family CO, Table 2, Figure 3),
11 patients from a Danish family (Family DK, Table 2, Figure 4),
two siblings from an English family (HO1.1 and HO1.2,
Tables 2 and 3), one American (BE, Tables 2 and 4) and two
unrelated Japanese patients (JP1 and JP2 Tables 2 and 4).
The CO family includes three patients, from three
generations (Figure 3). The mean age of onset is 12 years
(range, 8–18). A total of more than 50 tumors were observed
in the patients and the average number of tumors per patient
was more than 20. Tumors were located on their nose, front,
ears, lower lip, chin, neck, and anterior chest, and most of
them were excised (Table 2). These lesions were confirmed to
have the histological appearances of a KA or a well-
differentiated SCC.
The DK family comprises 11 patients, from three genera-
tions (Figure 4). The mean age of onset is 52.6 years (range,
30–81). A total of 44 tumors were observed in the patients
Table 1. Tumor distribution in the Scottish patients
Head Upper limbs Lower limbs Trunk
Males No. of tumors (range) 80 (3–14) 6 (0–3) 5 (0–2) 6 (0–4)
% of tumors 82.47% 6.19% 5.15% 6.19%
No. of males n=11 (100%) n=4 (36.36%) n=2 (18.18%) n=3 (27.27%)
Females No. of tumors (range) 464 (1–97) 62 (0–17) 107 (0–24) 4 (0–3)
% of tumors 72.84% 9.73% 16.80% 0.63%
No. of females n=26 (100%) n=13 (50%) n=17 (65.38%) n=2 (7.69%)
Table 2. Tumor distribution in the non-Scottish patients
Current age
Age of
onset
Total no.
of lesions
No. of lesions
in the head
No. of lesions
in the limbs
No. of lesions
in the trunk
No. of lesions
excised Radio-therapy
COI.2 64 10s 420 420 0 2 21 Yes
COII.2 41 18 22 20 0 2 19 No
COIII.1 13 8 2 1 1 0 2 No
DKI.1 Deceased 67 4 4 0 0 3 Yes
DKII.2 Deceased 75 1 1 0 0 0 Yes
DKII.3 93 81 1 0 1 0 0 No
DKII.6 Deceased 41 2 2 0 0 2 No
DKII.8 73 60 2 0 2 0 2 No
DKIII.3 57 43 23 10 13 0 15 Yes
DKIII.5 52 50 1 1 0 0 0 No
DKIII.7 44 30 7 5 2 0 4 No
DKIII.8 57 50 1 0 1 0 0 No
DKIII.9 53 48 1 0 1 0 0 No
DKIII.11 41 34 1 1 0 0 1 No
HO1.1 52 30s 420 410 0 410 1 Yes
HO1.2 49 46 420 420 0 0 0 No
JP1 39 27 440 420 420 0 0 No
JP2 33 30 1 1 0 0 1 No
BE 27 9 420 410 410 0 0 No
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and the average number of tumors per patient was four
(range, 1–23). Tumors were located equally on the head
(45.94%) and limbs (54.06%). The majority of tumors were
excised (61.36%). Histological analysis was performed on 32
lesions and 21 of them were classified as KAs, whereas the
remaining ones were described as well-differentiated SCCs.
The HO family includes two siblings, HO1.1 and HO1.2,
who developed their first tumors in their late 30s and middle
40s, respectively. So far, they both have had more than 20
lesions, mainly located on their face and trunk (Table 2).
Biopsies of some of these lesions showed histologic features
of KA or well-differentiated SCC. The father of HO1.1 and
HO1.2 was diagnosed with a metastatic SCC, with an
unknown primary, at age 70.
The clinical features and histological analysis of JP1, JP2,
and BE have been already presented and discussed in
previous publications (Koga et al., 2003; Kato et al., 2004;
Feldman and Maize, 2007). A brief summary is reported in
Table 2.
If we compare the median age of onset in the different
MSSE families, we can observe that family CO has the earliest
age (12 years; Table 2), followed by the Scottish families
(25.1 years; Figure 2). Both the families, DK and HO, have a
much later median age of onset (52.6 and 40 years,
respectively; Table 2). The distribution of the tumors
is also quite different, with no lesion in the limbs reported
in families CO and HO (Table 2), and no lesion in the
trunk in family DK, in JP1 and BE. The number of lesions
developed is also quite variable, with only one or two lesions
reported for most family DK patients (with the exception of
DKI.1, DKIII.3, DKIII.7; Table 2) and more than 20 lesions
found in the affected patients of families CO and HO
(Table 2).
Response to radiotherapy in the MSSE patients
Six of the MSSE patients described in this report underwent
radiotherapy (MA1.2, COI.2, HO1.1, DKI.1, DKII.2, and
DKIII.3).
COI.2 underwent radiation therapy on her face, but no
records are available regarding the outcome of this treatment.
None of the three patients of family DK who underwent
radiotherapy (DKI.1, DKII.2, and DKIII.3) had any sign of
aggravation after the treatment.
In contrast, patients MA1.2 and HO1.1 developed multi-
ple skin tumors in the radiation field. MA1.2 had a rapidly
growing, moderately well differentiated, SCC removed from
her left cheek in 1992. Although the excision margins were
quite clear, lymphatic permeation was noted and radial
radiotherapy was given, to prevent metastatic spread. Within
two months, MA1.2 developed myriads of squamo-prolifera-
tive lesions in the irradiated area of the skin, which included
her left cheek, the left side of her neck and her left pinna. The
lesions were treated unsuccessfully with interferon alpha/2B
and major reconstructive surgery was required following
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Figure 3. Haplotype analysis of an Italian MSSE family (CO) with eight informative markers. All the affected individuals have the same at-risk haplotype
(boxed), which is not shared by unaffected members of the family.
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excision of the affected area. Histology showed de novo SCCs
rather than metastatic lesions.
At 49 years, HO1.1 developed a keratotic lesion inside his
left nostril and underwent radiotherapy, which caused the
development of multiple keratotic and ulcerated papules and
plaques in the radiotherapy field as well as a yellowish
plaque over the left cheek close to the site of the previous
SCC excision. The patient started treatment with an oral RAR
retinoid, acitretin (50 mg/day), 3 months after completion of
radiotherapy, resulting in a complete remission.
None of the Scottish MSSE patients sharing the same at-
risk haplotype have had radiation therapy in recent years.
Haplotype analysis in one MSSE family of Scottish origin
Haplotype analysis of a woman of Scottish origin and her son
(MA1.2 and MA2.1, respectively), using the eight markers
D9S197; D9S196; ZNF169; D9S280; AFM070; FANCC1;
FANCC2; and D9S1809, demonstrated that their disease
associated haplotype was different from the shared haplotype
of the affected individuals in the other Scottish families
(Table 3).
This could suggest that MSSE is not only caused by a single
founder mutation in the Scottish population.
Haplotype analysis in MSSE families of non-Scottish origin
We performed haplotype analysis on MSSE families of non-
Scottish origin with the eight markers D9S197; D9S196;
ZNF169; D9S280; AFM070; FANCC1; FANCC2; and
D9S1809. In particular, we genotyped family CO (a three-
generation family from Italy) (Figure 3), seven of the affected
members of family DK (a three-generation Danish family)
(Figure 4), two affected siblings from London (HO 1.1 and
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Figure 4. Haplotype analysis of a Danish MSSE family (DK) with eight informative markers. All the affected individuals have the same at-risk haplotype
(boxed), which is not shared by unaffected members of the family.
Table 3. Haplotype analysis of two related Scottish
patients (MA1.2 and MA2.1), with eight informative
markers
Scottish at risk haplotype MA1.2 MA2.1
D9S197 211 208/210 208/210
D9S196 255 259 259
ZNF169 178 162 162
D9S280 153 153 153
AFM070 186 188/190 188/190
FANCC1 139 141 141
FANCC2 118 114 114
D9S1809 132 132 132
MA1.2 and MA2.1 share an identical at-risk haplotype, which is not the
same of the other Scottish families (where the at-risk allele for a marker
could not be determined, both alleles have been indicated).
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HO 1.2; Table 4), one American patient (BE, Table 4)
and two unrelated Japanese patients (JP1 and JP2; Table 4).
The at-risk haplotypes for families CO (Figure 3, in box),
DK (Figure 4, in box), and HO (Table 4) are different
from each other and, more importantly, they are all different
from the shared haplotype of the affected individuals
in the Scottish families. The disease-associated haplotypes
in BE, JP1, and JP2 could not be determined, because they
were the only affected individuals of their families from
whom we could obtain DNA samples. None of the
three, however, share common alleles with the Scottish
families for most of the markers analyzed, indicating that the
disease has also arisen independently in these patients
(Table 4). MSSE cannot therefore be solely caused by a
single founder mutation and it is probably less rare than
originally thought.
The three affected individuals of family CO share the same
allele for the eight polymorphic markers linked to the MSSE
locus. However, a recombination event between ZNF169
and D9S196 (Figure 3) suggests that the MSSE locus is most
likely to lie proximal to ZNF169. Individual II-3 is in his early
40s and still unaffected. He has inherited the high-risk
haplotype at ZNF169; D9S280; AFM070; FANCC1;
FANCC2; D9S1809; and more distal markers, and the low-
risk haplotype at D9S197; D9S196; and more proximal
markers. Considering that 78% of affected individuals have
developed a skin tumor by 40 years of age (Figure 2), and that
CO II-3 is in his early 40s and is still unaffected, it is probable
that this individual is unaffected and thus that the MSSE locus
is proximal to ZNF169. This recombination event suggests
that the MSSE locus may lie in an interval of o1 Mb
(776 343 bp) between D9S197 and ZNF169.
The seven affected members analyzed in family DK all
share the same haplotype for the eight markers listed above
(Figure 4). There is no evidence of recombination between
these makers and the MSSE locus. The segregation of the
microsatellite markers in family DK is compatible with
linkage to the MSSE locus (maximum lod score of 1.46 for
marker ZNF169 at recombination fraction 0.0).
Identification of candidate genes in the MSSE locus and
mutation analysis
We are currently sequencing 14 known genes (NINJ1,
WNK2, C9orf10, PHF2, BARX1, PTP9Q22, ZNF169,
Q9UFB1, HIATL1, FBP2, FBP1, C9orf3, FANCC, and PTCH)
(http://genome.ucsc.edu/ and http://www.ensembl.org) from
the MSSE candidate region between markers D9S197 and
D9S1809 (Table 5 and Figure S1), in a group of nine patients
representing MSSE families with different disease associated
haplotypes (Sc1&2, MA1.2, COI.2, DKII.2, HO1.1, BE, JP1,
and JP2).
We have already analyzed 12 of the candidate genes,
including NINJ1, WNK2, c9orf10, PHF2, BARX1, and
PTP9Q22, which are located within the narrower MSSE
region, proximal to ZNF169, identified by the recombination
event in COII-3. For each gene, we have sequenced every
exon and at least 100 bp of the flanking introns (primers
sequences provided as Table S1) in the nine members of the
selected group. We have not detected a mutation, but we
have identified several polymorphisms (45 in total) in most of
the candidate genes (Table 5). Large deletions spanning a
polymorphism can be excluded in families with an affected
member heterozygous for those rearrangements.
We have also sequenced a cluster of three miRNA genes
(Let-7a-1, Let-7f-1, or Let-7d) that lie in the interval between
D9S196 and ZNF169, but did not identify any abnormality.
DISCUSSION
The great majority of MSSE cases have been attributed to a
founder mutation that occurred in the west of Scotland at the
end of the 18th century. Nine Scottish MSSE families were
identified and linkage analysis showed that they were
carrying the same at-risk haplotype, confirming the common
origin of their mutation. We recently acquired patients of
non-Scottish origin whose symptoms were very similar to
those reported for MSSE. An exhaustive clinical and
histological analysis further suggested that their clinical
phenotype was effectively indistinguishable from MSSE.
Linkage analysis confirmed that their at-risk haplotype
Table 4. Haplotype analysis of two British MSSE patients (HO1.1 and HO1.2), on two unrelated Japanese patients
(JP1 and JP2), and an American patient (BE), with eight informative markers
Scottish at-risk haplotype HO1.1 HO1.2 JP1 JP2 BE
D9S197 211 209 209 198/208 198/208 208/209
D9S196 255 260 260 259/261 258/258 257/259
ZNF169 178 167 167 171/182 171/178 167/180
D9S280 153 153 153 153/153 135/153 149/153
AFM070 186 190/192 190/192 186/192 186/186 186/196
FANCC1 139 141/147 141/147 141/143 147/147 141/143
FANCC2 118 114 114 116/116 114/118 114/118
D9S1809 132 118/127 118/127 118/127 128/132 118/127
MSSE, multiple self-healing squamous epithelioma.
Note that none of the five patients share the same at-risk haplotype of the Scottish families. HO1.1 and HO1.2, who are siblings, share an identical at-risk
haplotype (where the at-risk allele for a marker could not be determined, both alleles have been indicated).
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segregated with the condition. The at-risk haplotype of family
CO, however, was different from the one of family DK and
HO, and, more importantly, they were all different from the
shared haplotype of the affected individuals in the original
Scottish families. MSSE is therefore not solely caused by a
founder mutation and is less rare than originally thought.
Table 5. Mutation screening of the candidate genes for MSSE
Gene Function Size Polymorphism Heterozygotes
NINJ1 Nerve injury-induced protein 1 12 791 bp (four exons) A-G intron 3
A-G* exon 4
C-T* exon 4
MA, CO
MA
JP
WNK2 Protein kinase 135 462 bp (29 exons) G-C intron 3
G-A* exon 7
A-T intron 8
G-A* exon 11
G-A* exon 11
C-T* exon 11
C-T intron 12
T-C intron 13
C-T* exon 19
G-A intron 26
MA, JP1, BE
CO, BE
Sc1&2, CO, JP1, HO
BE
Sc1&2, JP1, BE
Sc1&2
CO
CO
BE
BE
C9orf10 DNA polymerase 112 598 bp (18 exons) NO polymorphism detected
PHF2 PHD finger protein 102 750 bp (22 exons) G-A intron 2
G-A intron 2
C-T intron 3
C-T exon 4
G-A intron 5
C-T intron 6
A-G intron 6
T-C intron 11
G-A intron 13
C-T intron 13
C-T intron 15
A-G intron 17
T-C intron 17
in frame del in exon 21
polyG exon 22
C-A exon 22
A-G exon 22
C-T exon 22
C-A exon 22
CO, MA, BE
CO, HO, DK
Sc1&2, CO, HO
MA, BE
MA
Sc1&2, CO, HO, DK
HO
CO, BE, JP1, HO
HO
HO, DK
MA, BE
Sc1&2, CO, JP2
Sc1&2, CO, JP2
Sc1&2, Be, Co
Sc1&2, CO, JP1
JP1, MA
Sc1&2, CO, JP1, HO
BE, MA
Sc1&2, CO, HO
BARX1 Homeobox protein barh-like1 3431 bp (four exons) T-C exon 4
G-A exon 4
BE, HO
CO
PTP9Q22 Protein tyrosine phosphatase 79 060 bp (10 exons) C-G intron 2 Sc1&2
ZNF169 Zinc finger protein 42 115 bp (six exons) delCG exon 1
C-T* exon 4
C-G exon 6
MA
MA
Sc1&2
Q9UFB1 DNA binding protein 5988 bp (six exons) A-G exon 6 Sc1&2, CO
HIATL1 Hippocampus abundant transcript-like1 19 898 bp (eight exons) A-G intron 1
A-T intron 4
G-A intron 7
BE
BE
BE, HO
FBP2 Fructose 1,6-bisphosp iso2 35 071 bp (seven exons)
FBP1 Fructose 1,6-bisphosphatase 36 381 bp (seven exons)
C9orf3 Aminopeptidase 171 252 bp (15 exons) NO polymorphism detected
FANCC Fanconi anemia group C protein 147 585 bp (15 exons) NO polymorphism detected
PTCH Patched protein homolog 1 63 743 bp (25 exons) C-G intron 2
C-G intron 11
delT exon 25
Sc1&2
Sc, MA
Sc1&2, MA,
MSSE, Multiple self-healing squamous epithelioma.
Fourteen genes are mapped within the MSSE candidate locus. The 12 genes we have analyzed are in bold. Sc1&2 are a father and a son from one of the
Scottish families with the same at-risk haplotype. The nucleotide changes marked with an asterisk are non-synonymous. Novel single nucleotide
polymorphisms are underlined.
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The diverse genetic basis of this condition has been further
confirmed by haplotype analysis of an additional family with
the MSSE phenotype originating from the west of Scotland
(MA1.2 and MA2.1), who has a different disease-associated
haplotype. It seems therefore that MSSE is not after all caused
by a single founder mutation even among the Scottish
population. This could explain why two of the 11 Scottish
families used for linkage analysis have different at-risk alleles
for some of the markers analyzed in previous studies (Goudie
et al., 1993, Richards et al., 1997).
The disease-associated haplotypes in the American and
Japanese patients pedigrees could not be determined
unambiguously, because samples for molecular genetic
analysis were only available from one affected member of
each family. JP1, JP2, and BE, however, have typical MSSE
clinical features and they are most likely to have independent
mutations in the MSSE gene, although genetic heterogeneity
cannot be ruled out. JP1 and JP2 do not share common alleles
at most marker loci, providing little evidence for a founder
mutation in Japan.
We think it is extremely important for physicians to be
aware that MSSE is more common, with a wider geographical
distribution than was originally thought, and that the
condition may be under recognized. It is indeed very difficult
to distinguish between an individual skin lesion caused by
MSSE and a KA or a SCC. The literature is divided as to
whether MSSE lesions have unique distinguishing histological
features or lie on a spectrum between a KA and a well-
differentiated SCC (Clausen et al., 2006). Features may vary
depending on the stage of the lesion at the time of excision
and on the body site (reviewed by McKee et al., 2005;
Weedon, 2002). Early lesions are in keeping with well-
differentiated SCC. Within 2–4 months, lesions regress and
the infiltrating columns may become increasingly keratinized
and discharge a keratin plug or they may undergo necrosis. A
dense infiltrate of lymphocytes may be seen, but their role in
relation to regression is unknown. Ultimately a fibrous scar
forms. Local invasion occurs in vertical columns, keratiniza-
tion is prominent, mitoses are present in low numbers and
lymphatic invasion is rare.
The phenotypic variability among the MSSE families,
including age of onset, tumors number, and distribution,
might imply the existence of mutations of different severity
within the same MSSE gene. But the condition can also vary
in severity between affected members of the same family,
suggesting that other non-genetic factors can affect the
phenotype. The age of onset of the condition, for example,
is very variable in the Scottish families with the same at-risk
haplotype, where 20% of patients have not developed their
first tumor by 50 years of age (Figure 2). MSSE patients in
family DK have a milder phenotype, with a late age of onset
and, in some cases, only one lesion (DKII.2, DKII.3, DKIII.5,
DKIII.8, DKIII.9, DKIII.11), but they all share the same at-risk
haplotype, compatible with linkage to the MSSE locus. Late
age of onset is typical of the Grzybowski type of KA, but this
is a rare sporadic disorder, characterized by hundreds of
eruptive follicular papules (Consigli et al., 2000, Haas et al.,
2002).
It should be noted that six of the patients described in this
report (MA1.2, COI.2, HO1.1, DKI.1, DKII.2, and DKIII.3)
had radiotherapy and that two of them (MA1.2 and HO1.1)
subsequently developed multiple skin tumors in the radiation
field (no records are available for patient COI.2). Radio-
therapy might therefore aggravate the MSSE phenotype, as
previously indicated by a case of fatal local invasion in a
patient who underwent radiation therapy (Chakrabarty and
Perks, 1996). Although family DK appears to have a milder
phenotype and have not had adverse reactions to radio-
therapy, linkage studies suggest that their condition is
attributable to a mutation in the MSSE locus. None of the
Scottish MSSE patients have had radiation therapy in recent
years.
It is our current priority to identify the candidate gene for
MSSE, which could be a tumor suppressor gene, as indicated
by studies on loss of heterozygosity within the MSSE region
(Bose et al., 2006). We have sequenced a cluster of three
miRNA genes (Let-7a-1, Let-7f-1, or Let-7d) and the coding
regions of 12 of the 14 genes within the 4 cM locus of MSSE
(NINJ1, WNK2, C9orf10, PHF2, BARX1, PTP9Q22, ZNF169,
Q9UFB1, HIATL1, C9orf3, FANCC, and PTCH), and found
several rearrangements. Large deletions spanning a poly-
morphism could be excluded in families with an affected
member heterozygous for those rearrangements.
We hope that the here reported description of the common
clinical features in MSSE, including the type, number, and
location of tumors, will serve to aid and improve the
accuracy of its diagnosis.
MATERIALS AND METHODS
Patients and samples
All aspects of this study were carried out in accordance with the
Declaration of Helsinki Principles and complied with the require-
ments of the local institutional ethical review boards. All individuals
gave their fully informed consent for blood and tissue sample
collection. DNA was extracted from 186 individuals, including 64
affected and 110 unaffected or at-risk members from 11 Scottish
MSSE families, one Italian (CO), one Danish (DK), and one English
family (HO), plus 12 isolated MSSE cases. All the affected individuals
were examined for signs of active or healed skin tumors by one of the
authors. A detailed family history and a history of the age of onset,
distribution and clinical course of skin lesions were obtained from
each patient.
Histological analysis of MSSE tumors
Skin biopsies were obtained with informed consent from the MSSE
patients involved in this study, and processed by standard methods
through formalin fixation and embedding in paraffin wax. Sections
(5mm) were cut, mounted on slides, and stained with hematoxylin
and eosin.
Linkage studies and haplotype analysis
DNA from patients and their families was amplified for the
microsatellite markers D9S197; D9S196; ZNF169; D9S280;
AFM070; and D9S1809 (Figure S1) using published primers
fluorescently labelled (http://www.gdb.org). PCR reactions were
performed in a total volume of 12.5 ml containing 75 ng of DNA,
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42 ng of each primer, 2 mM deoxynucleoside triphosphates, and 1 U
of HotStarTaq DNA Polymerase (QIAGEN Ltd, West Sussex, UK).
After 15 minutes of denaturation at 941C, samples were amplified for
40 cycles of 30 seconds at 941C, 1 minute at 581C, and 2 minutes at
721C, using a Biometra PCR machine (Whatman-Biometra, Goettin-
gen, Germany). Two CA repeats in intron 1a and intron 2 of the
FANCC gene (Savoia et al., 1996) were amplified using the above
reagents and PCR conditions. PCR products were directly sequenced
using BigDye terminator (Applied Biosystems, Warrington, UK) and
analyzed by capillary electrophoresis on an ABI 3100 Genetic
Analyzer (PerkinElmer, Boston, MA). Lod score on family DK was
calculated using the MLINK algorithm version of LINKAGE 5.1.
Mutation analysis
Using the program OLIGO 4.0, we designed forward and reverse
intronic primers to amplify every exon and at least 100 bp of
the flanking introns of all the candidate genes. Primers sequences
and annealing temperatures are provided as Supplementary Data
(Table S1). PCR reactions were performed as above indicated for
the haplotype analysis. PCR products were sequenced with an ABI
3100 Genetic Analyzer (PerkinElmer, Boston, MA), using their
respective forward and reverse primers.
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